Volume of Hypertonic Lactate (Totilac) for a 70-kg Adult
For a 70-kg adult patient, administer 175 mL (2.5 mL/kg) of hypertonic sodium lactate (Totilac) intravenously over 15-20 minutes.
Dosing Rationale
The standard dose of hypertonic sodium lactate for therapeutic use is 2.5 mL/kg, which translates to 175 mL for a 70-kg patient 1, 2. This volume delivers approximately 2.5 mmol/kg of sodium and has been consistently used across multiple clinical studies demonstrating both safety and efficacy.
Administration Protocol
- Infusion rate: Administer over 15-20 minutes 1, 2
- Maximum single dose: Do not exceed 3600 mL total volume in any patient 3
- Monitoring: Check serum sodium and osmolality within 6 hours of administration 4
- Re-dosing criteria: Do not re-administer until serum sodium < 155 mmol/L 4
Clinical Context and Effects
Hypertonic lactate at this dose produces predictable physiological effects:
Hemodynamic improvements include increased cardiac output (approximately 1.0 L/min increase), stroke volume elevation (11 mL increase), and improved left ventricular ejection fraction (5 percentage point improvement) 5. These cardiovascular benefits occur through reduced afterload and enhanced contractility while maintaining stable preload 5.
Intracranial pressure control is achieved with ICP reductions comparable to mannitol, with 96% of patients achieving satisfactory brain relaxation in neurosurgical settings 2, 6. The solution provides both osmotic effects and potential metabolic benefits as lactate serves as an alternative cerebral fuel source 7, 8.
Metabolic effects include a predictable rise in blood lactate (typically to 2.4 mmol/L from baseline 1.0 mmol/L), modest sodium increase (139 to 142 mmol/L), and alkalinizing effect with pH rising from 7.37 to 7.45 9, 5. These changes are well-tolerated and clinically acceptable.
Safety Considerations
Common side effects are limited to mild electrolyte shifts, primarily hypokalemia (observed in approximately 25% of patients) 2. No serious adverse events directly attributable to hypertonic lactate have been reported at this dosing regimen 1, 2.
Contraindications and cautions: While the solution contains potassium (4-5 mmol/L), this does not cause clinically significant hyperkalemia even in at-risk patients, as the potassium concentration is lower than plasma levels 10. However, monitor serum osmolality and do not exceed 320 mOsm/L 11, 4.
Age-Related Adjustments
For patients ≥ 65 years, consider reducing the total volume to 30 mL/kg (2100 mL for a 70-kg patient) rather than 40 mL/kg for safety reasons 3. Older patients demonstrate decreased distributional clearance and elimination clearance (50.2 mL/min vs. 156 mL/min in younger patients), necessitating more conservative dosing 3.
Comparison to Alternative Osmotherapy
Hypertonic lactate offers advantages over conventional therapies: it requires half the volume of mannitol (2.5 mL/kg vs. 5 mL/kg) to achieve equivalent ICP control 2, produces less acidosis than 0.9% saline 1, 9, and provides superior hemodynamic tolerance with improved cardiac function compared to hypertonic saline 9, 5.